Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies.
Journal: The Lancet. Respiratory medicine
Published: March 02, 2026
Impact of Sex on Prediction of Asthma Attacks by Clinical Risk Factors and Type 2 Biomarkers.
Journal: Chest
Published: September 22, 2025
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials.
Journal: The Lancet. Respiratory medicine
Published: December 09, 2024
Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics.
Journal: ERJ open research
Published: February 28, 2024
Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with Asthma.
Journal: American journal of respiratory and critical care medicine
Published: February 08, 2024
Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry.
Journal: Journal of asthma and allergy
Published: December 12, 2023
Dupilumab improves pediatric type 2 asthma outcomes independent of patient baseline characteristics.
Dupilumab improves pediatric type 2 asthma outcomes independent of patient baseline characteristics.
Journal: The journal of allergy and clinical immunology. In practice
Published: August 11, 2023
Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study.
Journal: The journal of allergy and clinical immunology. In practice
Published: July 21, 2023
Real-world effectiveness of dupilumab in patients with asthma: Findings from the US ADVANTAGE study.
Real-world effectiveness of dupilumab in patients with asthma: Findings from the US ADVANTAGE study.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: July 17, 2023
Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE).
Journal: The journal of allergy and clinical immunology. In practice
Published: June 30, 2023
Last Updated: 09/26/2026